Shortage reports
Actual shortage:
2 (1%)
Anticipated shortage:
0 (0%)
Avoided shortage:
11 (3%)
Resolved:
363 (97%)
376
Discontinuation Reports
To be discontinued:
2 (3%)
Discontinued:
59 (97%)
Reversed:
0 (0%)
61
4 (1%)
0 (0%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IMITREX NASAL SPRAY | 5MG | SPRAY | Resolved | 2017-05-19 | 2018-02-08 | 10741 |
| IMITREX NASAL SPRAY | 5MG | SPRAY | Resolved | 2018-10-26 | 2018-10-31 | 65623 |
| IMITREX NASAL SPRAY | 5MG | SPRAY | Resolved | 2021-06-30 | 2021-07-10 | 141713 |
| IMITREX NASAL SPRAY | 20MG | SPRAY | Resolved | 2017-04-06 | 2017-05-26 | 5841 |
| IMITREX NASAL SPRAY | 20MG | SPRAY | Resolved | 2020-04-03 | 2020-04-30 | 110863 |
| IMITREX NASAL SPRAY | 20MG | SPRAY | Resolved | 2018-03-09 | 2018-04-27 | 42337 |
| IMITREX NASAL SPRAY | 20MG | SPRAY | Resolved | 2019-04-18 | 2019-05-17 | 82069 |
| IMITREX NASAL SPRAY | 5MG | SPRAY | Resolved | 2021-12-10 | 2022-01-26 | 150930 |
| INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2019-02-19 | 2019-03-02 | 76337 |
| INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2019-12-18 | 2020-02-06 | 101563 |
| INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2022-12-16 | 2023-01-04 | 178691 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2021-11-26 | 2022-03-02 | 149987 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2018-12-12 | 2019-02-22 | 69396 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2019-05-17 | 2019-08-16 | 84337 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2020-02-21 | 2020-03-26 | 106829 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2023-11-23 | 2024-08-02 | 211335 |
| LAMICTAL | 25MG | TABLET | Resolved | 2017-09-14 | 2018-02-16 | 22120 |
| LAMICTAL | 100MG | TABLET | Resolved | 2018-03-16 | 2018-05-26 | 43073 |
| LAMICTAL | 5MG | TABLET | Resolved | 2018-01-19 | 2018-01-23 | 36734 |
| LAMICTAL | 5MG | TABLET | Resolved | 2017-06-09 | 2017-09-13 | 12467 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AMERGE | 2.5MG | TABLET | Discontinued | 2021-10-28 | 2022-12-02 | 148430 |
| AMERGE | 1MG | TABLET | Discontinued | 2021-10-28 | 2022-08-09 | 148427 |
| AVANDAMET | 500MG 2MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8077 |
| AVANDAMET | 1000MG 4.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8084 |
| AVANDAMET | 1000MG 2.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8081 |
| AVANDAMET | 500MG 4MG | TABLET | Discontinued | 2017-04-25 | 2017-05-04 | 8087 |
| AVANDIA | 8MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113317 |
| AVANDIA | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-09-01 | 113311 |
| AVANDIA | 4MG | TABLET | Discontinued | 2020-04-27 | 2020-12-11 | 113314 |
| CEFTIN - TAB 250MG | 250MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121046 |
| CEFTIN - TAB 500MG | 500MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121049 |
| CLAVULIN 500 F TAB | 125MG 500MG | TABLET | Discontinued | 2024-02-02 | 2024-02-02 | 218240 |
| CLAVULIN 875 | 125MG 875MG | TABLET | Discontinued | 2024-01-18 | 2024-01-18 | 216509 |
| CLINDETS | 1% | PAD | Discontinued | 2017-09-19 | 2017-09-19 | 22562 |
| CLINDOXYL GEL | 5% 1% | GEL | Discontinued | 2025-10-29 | 2025-11-14 | 270515 |
| COACTIFED | 30MG 2MG 10MG | SYRUP | Discontinued | 2018-06-13 | 2018-06-13 | 52332 |
| CYCLOCORT | 0.1% | LOTION | Discontinued | 2017-09-19 | 2017-09-19 | 22565 |
| CYCLOCORT | 0.1% | CREAM | Discontinued | 2017-11-02 | 2018-01-31 | 27816 |
| CYCLOCORT | 0.1% | OINTMENT | Discontinued | 2017-09-19 | 2018-03-15 | 22568 |
| EMO CORT CREAM 2.5% | 2.5% | CREAM | Discontinued | 2017-09-19 | 2017-09-19 | 22574 |